These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus. Pefanis A, Thauvin-Eliopoulos C, Eliopoulos GM, Moellering RC. Antimicrob Agents Chemother; 1993 Mar; 37(3):507-11. PubMed ID: 8460919 [Abstract] [Full Text] [Related]
6. Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides. Gavaldà J, Torres C, Tenorio C, López P, Zaragoza M, Capdevila JA, Almirante B, Ruiz F, Borrell N, Gomis X, Pigrau C, Baquero F, Pahissa A. Antimicrob Agents Chemother; 1999 Mar; 43(3):639-46. PubMed ID: 10049280 [Abstract] [Full Text] [Related]
7. Efficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin. Yao JD, Thauvin-Eliopoulos C, Eliopoulos GM, Moellering RC. Antimicrob Agents Chemother; 1990 May; 34(5):827-30. PubMed ID: 2141778 [Abstract] [Full Text] [Related]
8. Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis. Lavoie SR, Wong ES, Coudron PE, Williams DS, Markowitz SM. Antimicrob Agents Chemother; 1993 Jul; 37(7):1447-51. PubMed ID: 8363374 [Abstract] [Full Text] [Related]
14. Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis. López P, Gavaldà J, Martin MT, Almirante B, Gomis X, Azuaje C, Borrell N, Pou L, Falcó V, Pigrau C, Pahissa A. Antimicrob Agents Chemother; 2001 May; 45(5):1387-93. PubMed ID: 11302800 [Abstract] [Full Text] [Related]
18. Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum. Gavaldà J, Cardona PJ, Almirante B, Capdevila JA, Laguarda M, Pou L, Crespo E, Pigrau C, Pahissa A. Antimicrob Agents Chemother; 1996 Jan; 40(1):173-8. PubMed ID: 8787901 [Abstract] [Full Text] [Related]